Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;106:2346-2350
Published online before print October 14, 2002, doi: 10.1161/01.CIR.0000036595.92742.69
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
106/18/2346    most recent
01.CIR.0000036595.92742.69v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seshadri, N.
Right arrow Articles by Ellis, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seshadri, N.
Right arrow Articles by Ellis, S. G.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Angioplasty
*Coronary Artery Bypass Surgery
Related Collections
Right arrow CV surgery: coronary artery disease

(Circulation. 2002;106:2346.)
© 2002 American Heart Association, Inc.


Clinical Investigation and Reports

Emergency Coronary Artery Bypass Surgery in the Contemporary Percutaneous Coronary Intervention Era

Niranjan Seshadri, MD; Patrick L. Whitlow, MD; Naveen Acharya, MD; Penny Houghtaling, MS; Eugene H. Blackstone, MD; Stephen G. Ellis, MD

From the Departments of Cardiology (N.S., P.L.W., S.G.E.), Internal Medicine (N.A.), Biostatistics and Epidemiology (P.H., E.H.B.), and Cardiothoracic Surgery (E.H.B.), Cleveland Clinic Foundation, Cleveland, Ohio.

Correspondence to Patrick L. Whitlow, MD, Director, Interventional Cardiology, Cleveland Clinic Foundation, Desk F-25, 9500 Euclid Ave, Cleveland, Ohio 44195. E-mail whitlop{at}ccf.org


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowAppendix 1
down arrowReferences
 
Background— Since the advent of percutaneous coronary interventions (PCIs), technological advances, adjunctive pharmacotherapy, and increasing operator experience have contributed to lowering the occurrence of major complications. However, emergency coronary artery bypass surgery (CABG) for failed PCI is still associated with important morbidity and mortality, even in the era of coronary stenting. We sought to determine the prevalence, indications, predictors, and complications of emergency CABG after PCI in the past decade.

Methods and Results— We reviewed 18 593 PCIs performed from 1992 through 2000. There was a need for emergency CABG in 113 (0.61%) cases. The major indications were extensive dissection (n=61, 54%), perforation/tamponade (n=23, 20%), and recurrent acute closure (n=23, 20%). Prevalence of emergency CABG decreased from 1.5% of PCIs in 1992 to 0.14% in 2000 (P<0.001). Independent predictors of the need for emergency CABG included the worst ACC/AHA scoring of the intervened lesion (P<0.001) and female sex (P= 0.028), whereas history of prior bypass surgery and use of stents resulted in a decreased need for emergency CABG (P<0.001 for both). In patients undergoing emergency CABG, there were 17 (15%) in-hospital deaths, 14 (12%) perioperative Q-wave myocardial infarctions, and 6 (5%) cerebrovascular accidents.

Conclusions— The need for emergency CABG has considerably decreased over time. Risk factors include female sex and a higher ACC/AHA score of the intervened lesion. However, morbidity and mortality of emergency CABG remain high even in the new millennium.


Key Words: coronary disease • bypass • grafting • stents • angioplasty


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowAppendix 1
down arrowReferences
 
Since the advent of percutaneous coronary interventions (PCIs) in 1977,1 there has been a significant decline in the occurrence of major complications, perhaps as a result of technological and pharmacological advances such as stenting and use of platelet glycoprotein IIb/IIIa inhibitors.2 Despite this, emergency coronary artery bypass surgery (CABG) is still associated with a significant in-hospital morbidity and mortality.29 We sought to determine the prevalence, indications, predictors, and in-hospital complications of emergency CABG after PCIs in the stent era.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowAppendix 1
down arrowReferences
 
Study Population
From 1992 through 2000, 18 593 PCI procedures were performed at the Cleveland Clinic Foundation. Information was obtained from a computerized database that included demographics, detailed clinical history, and procedural data entered at the time of the PCI and updated by an independent auditor at the time of hospital discharge. In addition, a medical chart review was performed on all patients sent for emergency CABG. Our cardiothoracic surgical database was also interrogated to ensure all cases of emergency CABG were captured.

Definitions
Emergency CABG was defined as need for surgery after PCI for the following reasons: extensive dissection causing ischemia or threatened ischemia, recurrent acute closure, perforation or tamponade, hemodynamic instability, and other indications warranting CABG that was not electively scheduled.

In-hospital death was defined as death after emergency CABG during the index hospitalization. Perioperative Q-wave myocardial infarction was defined as the appearance of new Q waves (>=0.4 ms) in at least 2 consecutive leads after emergency CABG. Cerebrovascular accidents were defined as new neurological deficits or radiological evidence of new hemorrhagic or thrombotic intracerebral events after emergency CABG.

Statistical Analysis
Descriptive statistics are summarized for categorical variables as frequencies and percentages and compared using the {chi}2 test. Continuous variables, expressed as mean±SD, were compared using t tests. Univariate logistic regression analysis was performed to determine independent predictors of emergency CABG. Odds ratios and 95% CIs are provided for variables that were found to be significantly associated with emergency CABG (P<0.05). To confirm independent predictive value, a multivariable logistic regression model was formed from all baseline clinical and angiographic variables (Appendix) using a guided stepwise approach. Because of the changes in practice over time (ie, increased use of stents and platelet glycoprotein IIb/IIIa inhibitors), interactions of variables with time were also considered in the analysis. A value of P<0.05 was considered statistically significant for retention of variables in the final model. All statistical analyses were done using the SAS system (version 8.0).


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowAppendix 1
down arrowReferences
 
Prevalence of Emergency CABG
Of the 18 593 PCIs, 113 (0.6%) cases required emergency CABG according to our definition. The baseline clinical and procedural characteristics of the 113 compared with the 14 411 patients who did not require emergency CABG are shown in Tables 1 and 2, respectively. The prevalence of emergency CABG from 1992 through 2000 is shown in Figure 1. There was a significant >10-fold decline in the prevalence of emergency CABG from 1.5% in 1992 to 0.14% in 2000 (P<0.001). In recent years (1996 onwards), stented patients were less likely to undergo emergency CABG compared with nonstented patients (P<0.001) (see Figure 2).


View this table:
[in this window]
[in a new window]
 
TABLE 1. Baseline Clinical Characteristics of All Patients



View larger version (11K):
[in this window]
[in a new window]
 
Figure 1. Prevalence of emergency CABG after percutaneous coronary interventions from 1992 through 2000.



View larger version (15K):
[in this window]
[in a new window]
 
Figure 2. Prevalence of emergency CABG in stented and nonstented patients from 1992 through 2000.


View this table:
[in this window]
[in a new window]
 
TABLE 2. Procedural Characteristics of All Patients

Stent and Platelet Glycoprotein IIb/IIIa Inhibitor Use
The use of stents and platelet glycoprotein IIb/IIIa inhibitors in all patients is shown in Figure 3. Stent and platelet glycoprotein IIb/IIIa inhibitor use increased from 5% (1992) to 56% (1996) and 0% (1992) to 29% (1996) of all PCIs, respectively. From 1997 to 2000, use of stents and IIb/IIIa inhibitors increased from 62% to 81% and 37% to 88%, respectively.



View larger version (15K):
[in this window]
[in a new window]
 
Figure 3. Use of stents and platelet glycoprotein IIb/IIIa inhibitors in all patients from 1992 through 2000.

Indications for Emergency CABG
The predominant indications for emergency CABG were extensive dissection, perforation/tamponade, and recurrent acute closure in 61 (54%), 23 (20%), and 23 (20%) cases, respectively. Other indications were hemodynamic instability in 3 (3%), aortic dissection in 2 (2%), and guidewire fracture in 1 (1%).

There were 84 cases of emergency CABG from 1992 through 1996 and 29 cases from 1997 through 2000. Extensive dissection as an indication for emergency CABG fell from 60% to 38% in these two time periods. The occurrence of perforation/tamponade was 19% from 1992 through 1996 and 24% from 1997 through 2000. Recurrent acute closure as an indication for emergency CABG was 19% from 1992 through 1996 and 24% from 1997 through 2000.

Predictors of Emergency CABG
Patients who required emergency CABG were more likely to be female (P=0.01), have higher left ventricular ejection fractions (P=0.002), have an acute myocardial infarction as an indication for the PCI (P=0.01), and have an intra-aortic balloon pump inserted before (<=48 hours) the PCI (P<0.001). Patients requiring emergency CABG were also more likely to have received a balloon angioplasty alone (P= 0.003) and also to have had a relatively higher number of type C lesions (P<0.001) and a lesser number of type A lesions (P<0.001). In addition, the worst ACC/AHA score of the intervened lesion (<0.001) correlated with the need for emergency CABG. Patients with history of a prior bypass surgery (P<0.001) and those who received stents (P< 0.001) and platelet glycoprotein IIb/IIIa inhibitors (P<0.001) were less likely to require emergency CABG (Tables 1 through 3).


View this table:
[in this window]
[in a new window]
 
TABLE 3. Univariate Correlates of the Need for Emergency CABG After PCIs

In multivariable analysis, the worst ACC/AHA score of the intervened lesion (P<0.001) and female sex (P= 0.028) were predictive of the need for emergency CABG. Those with a history of a prior bypass surgery were less likely to undergo emergency CABG (P<0.001). Those who received stents in the recent years (1996 onwards) had a decreased need for emergency CABG (P<0.001) (Table 4).


View this table:
[in this window]
[in a new window]
 
TABLE 4. Multivariable Logistic Regression Model for Predictors of Emergency CABG After PCIs

Operator Experience and Need for Emergency CABG
There was no difference in need for emergency CABG following PCIs performed by operators performing >75 cases per year compared with those performing <75 cases per year (0.77% versus 0.83%, respectively, P=0.8).

In-Hospital Complications of Emergency CABG
There were 40 (35%) additional in-hospital complications in the patients undergoing emergency CABG. There were 17 (15%) deaths, 14 (12%) perioperative Q-wave myocardial infarctions, 6 (5%) cerebrovascular accidents, 2 (2%) patients with respiratory failure postoperatively requiring intubation >5 days, and 1 (1%) patient with hemodynamic instability requiring extracorporeal circulatory support postoperatively. Among 84 patients undergoing emergency CABG from 1992 through 1996, there were 29 (35%) complications (11 deaths, 14 perioperative Q-wave myocardial infarctions, 3 cerebrovascular accidents, and 1 respiratory failure). Among 29 patients undergoing emergency CABG from 1997 through 2000, there were 11 (38%) complications (6 deaths, 3 cerebrovascular accidents, 1 extracorporeal mechanical oxygenation, and 1 respiratory failure).

To determine if sending fewer patients to emergency CABG resulted in a potentially compensatory increased incidence of other serious complications, the incidence of Q-wave myocardial infarction and death was assessed over time. Among patients undergoing elective PCI not requiring emergency CABG, there was a significant decline in the incidence of death and Q-wave myocardial infarction from 1992 to 2000 (P<0.001). From 1992 through 1996, there were 48 Q-wave myocardial infarctions (0.7%) and 140 deaths (2.0%) among 6614 patients undergoing elective PCI and not requiring emergency CABG. From 1997 through 2000, there were 15 Q-wave myocardial infarctions (0.2%) and 62 deaths (0.9%) among 6825 patients undergoing elective PCIs and not requiring emergency CABG. Therefore, not only emergency CABG but also all major adverse events have significantly improved over the last decade.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowAppendix 1
down arrowReferences
 
In this study of 18 593 PCIs performed over a 9-year period from 1992 through 2000, we report a dramatic >10-fold decline in prevalence of emergency CABG after failed PCIs. In parallel, Q-wave myocardial infarction and death also significantly declined over time in patients undergoing elective PCI not requiring emergency CABG.

Independent risk factors predisposing a patient to emergency CABG included female sex and complex coronary lesions (of those requiring emergency CABG, 5% had type A lesions and 40% had type C lesions). Moreover, use of stents was independently associated with decreased need for emergency CABG, as was the history of prior bypass surgery. Furthermore, in this study, operator experience and use of platelet glycoprotein IIb/IIIa inhibitors did not have a bearing on need for emergency CABG after PCI. Despite the decline in emergency CABG in the era of stents, when required, emergency CABG is still associated with a high risk of major in-hospital adverse events.

Since the first reported case of percutaneous coronary intervention in 1977,1 surgical standby has been the norm. In an early experience of 50 cases, emergency CABG was required in 14%.1 In 2 large series reported by the National Heart, Lung and Blood Institute, emergency CABG was required in 6% of the cases between 1977 and 1981 and in 3% between 1985 and 1986.10 There has been an additional decline in the reported prevalence of emergency CABG in the 1990s. In a study of 5655 patients undergoing PCIs by Shubrooks et al,11 emergency CABG was required in 2.2% of the cases in 1992 to 1993 and 0.6% of the cases in 1997. We report a significant decline in the prevalence of emergency CABG from 1.5% in 1992 to 0.14% of all PCIs in 2000 in a single-center tertiary care setting (Figure 1).

The declining need for emergency CABG may be attributable to increased operator and laboratory experience, better percutaneous techniques, technological advances such as stents, and use of adjunctive pharmacotherapy such as platelet glycoprotein IIb/IIIa inhibitors. There could also be a higher threshold for sending patients for emergency CABG. In our study, use of stents was independently associated with a decreased need for emergency CABG. As stents became more widely available after 1995 to 1996, stented patients had a significant decline in the need for emergency CABG compared with the nonstented patients. Before the availability of stents, complications such as coronary dissections would have more frequently resulted in emergency surgery. There was a relatively lower number of emergency CABGs in the stented patients compared with those not receiving stents (Figure 2). Despite the benefit of platelet glycoprotein IIb/IIIa inhibitors in decreasing acute closure,12 the use of platelet glycoprotein IIb/IIIa inhibitors was not independently associated with a decreased need for emergency CABG in the present study. This likely reflects the analytic issues of a larger registry compared with dedicated placebo-controlled randomized trials. Although increased operator experience has been shown to be associated with better outcomes after PCI,13,14 in our study, operator experience did not have a bearing on prevalence of emergency CABG.

In parallel with decreased emergency CABG was a decrease in Q-wave myocardial infarction and periprocedural death in patients undergoing elective PCI and not requiring emergency CABG. Thus, the decreased utilization of emergency CABG did not result in a trade off of more severe adverse events of other categories. Rather, the data suggest that the overall safety of PCI has dramatically improved in the last decade.

Despite the low prevalence of emergency CABG in our institution, there was a high occurrence of in-hospital complications after emergency CABG. Several large studies from the mid 1980s to early 1990s have reported perioperative Q-wave myocardial infarction in 21% to 57% of patients and in-hospital mortality ranging from 3% to 19%.29 In the stent era, in-hospital complications after emergency CABG have remained high. In the study by Shubrooks et al,11 mortality and nonfatal Q-wave myocardial infarctions occurred in 29% and 14% of the cases, respectively, in 1997. In our study, in-hospital mortality and Q-wave myocardial infarction were 21% and 0%, respectively, from 1997 through 2000 compared with 13% and 17%, respectively, from 1992 through 1996.

Our study has some important limitations. It is an observational clinical study. There may have been a bias against taking patients with prior bypass surgery for an emergency reoperation, likely because of high occurrence of postoperative complications in emergency reoperations. Indeed, only 8% of the patients in the emergency CABG group had a history of prior bypass surgery compared with 29% in patients not requiring emergency CABG. However, fewer patients with a prior bypass surgery may experience tamponade from coronary perforations attributable to pericardial adhesions. In addition, the benefit of stents was likely overestimated, because our analysis did not take into consideration those patients in whom stents were intended to be used but could not be deployed.

In conclusion, we report a highly significant >10-fold decline in prevalence of emergency CABG from 1992 to 2000. Female sex and worse ACC/AHA score of the intervened lesion were independent predictors of the need for emergency CABG. Use of stents has resulted in a decreased need for emergency CABG. Despite this, however, emergency CABG is associated with a significant risk of major in-hospital adverse events, even in the new millennium.


*    Appendix 1
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*Appendix 1
down arrowReferences
 
Appendix
The following variables (and transformations of them) were considered in the multivariable analysis as possible predictors of emergency coronary bypass surgery: Age, sex, height, weight, NYHA class, acute myocardial infarction, unstable angina, history of recent myocardial infarction, history of prior myocardial infarction, recent positive stress test, angina class, heart rate and systolic blood pressure before the procedure, worst ACC score of any intervened lesion, left ventricular ejection fraction, degree of mitral regurgitation, restenotic lesion, history of prior bypass surgery, family history of heart disease, hypertension, diabetes, prior cerebrovascular accident or transient ischemic attack, renal insufficiency, chronic obstructive pulmonary disease, peripheral vascular disease, serum cholesterol, triglycerides, and high-density lipoprotein, present/former smoker, number of diseased vessels, intraaortic balloon pump use before the procedure (<=48 hours), heparin use, thrombolytic treatment (<=48 hours), drugs received <=24 hours before the procedure (ACE inhibitors, class-I antiarrhythmics, aspirin, ß-blockers, calcium channel blockers, oral/topical or intravenous nitrates, diuretics, and lipid-lowering agents), abciximab before or after procedure, any IIb/IIIa inhibitor use, balloon angioplasty alone, rotablator use, laser, stent, bailout stent, lesion location (such as proximal left anterior descending, mid/distal left anterior descending, and right coronary and circumflex coronary arteries), number of treated sites, longest lesion treated, average diameter of the treated lesion, and date of procedure. The interactions between date of procedure and age, stent, and platelet glycoprotein IIb/IIIa inhibitor use were also taken into consideration.

Received May 24, 2002; revision received August 20, 2002; accepted August 21, 2002.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
up arrowAppendix 1
*References
 
1. Gruntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med. 1979; 301: 61–68.[Abstract]

2. Meier B. Surgical standby for percutaneous transluminal coronary angioplasty. In: Topol EJ, ed. Textbook of Interventional Cardiology. 3rd ed. Philadelphia, Pa: WB Saunders; 1999: 466–474.

3. Cowley MJ, Dorros G, Kelsey SF, et al. Emergency coronary bypass surgery after coronary angioplasty: the National Heart, Lung, and Blood Institute’s Percutaneous Transluminal Coronary Angioplasty Registry experience. Am J Cardiol. 1984; 53: 22C–26C.[CrossRef][Medline] [Order article via Infotrieve]

4. Parsonnet V, Fisch D, Gielchinsky I, et al. Emergency operation after failed angioplasty. J Thorac Cardiovasc Surg. 1988; 96: 198–203.[Abstract]

5. Naunheim KS, Fiore AC, Fagan DC. Emergency coronary artery bypass grafting for failed angioplasty: risk factors and outcome. Ann Thorac Surg. 1989; 47: 616–623.

6. Bredee JJ, Bavinck JH, Berreklouw E, et al. Acute myocardial ischaemia and cardiogenic shock after percutaneous transluminal coronary angioplasty: risk factors for and results of emergency coronary bypass. Eur Heart J. 1989; 10 (suppl H): 104–111.[Abstract/Free Full Text]

7. Zapolanski A, Rosenblum J, Myler RK, et al. Emergency coronary artery bypass surgery following failed balloon angioplasty: role of the internal mammary artery graft. J Card Surg. 1991; 6: 439–448.[Medline] [Order article via Infotrieve]

8. Buffet P, Villemot JP, Danchin N, et al. Emergency coronary surgery after transluminal angioplasty: immediate results and long-term outcome of 100 operations [in French]. Arch Mal Coeur Vaiss. 1992; 85: 17–23.

9. Craver JM, Weintraub WS, Jones EL, et al. Emergency coronary artery bypass surgery for failed percutaneous coronary angioplasty: a 10-year experience. Ann Surg. 1992; 215: 425–433.[Medline] [Order article via Infotrieve]

10. Detre K, Holubkov R, Kelsey S, et al. Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981: the National Heart, Lung, and Blood Institute Registry. N Engl J Med. 1988; 318: 265–270.[Abstract]

11. Shubrooks SJ Jr, Nesto RW, Leeman D, et al. Urgent coronary bypass surgery for failed percutaneous coronary intervention in the stent era: Is backup still necessary? Am Heart J. 2001; 142: 190–196.[CrossRef][Medline] [Order article via Infotrieve]

12. Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-II. Lancet. 1997; 349: 1422–1428.[CrossRef][Medline] [Order article via Infotrieve]

13. Ellis SG, Weintraub W, Holmes D, et al. Relation of operator volume and experience to procedural outcome of percutaneous coronary revascularization at hospitals with high interventional volumes. Circulation. 1997; 95: 2479–2484.[Abstract/Free Full Text]

14. Ellis SG, De Cesare NB, Pinkerton CA, et al. Relation of stenosis morphology and clinical presentation to the procedural results of directional coronary atherectomy. Circulation. 1991; 84: 942–944.[Free Full Text]




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
M. A. Kutcher, L. W. Klein, F.-S. Ou, T. P. Wharton Jr, G. J. Dehmer, M. Singh, H. V. Anderson, J. S. Rumsfeld, W. S. Weintraub, R. E. Shaw, et al.
Percutaneous Coronary Interventions in Facilities Without Cardiac Surgery On Site: A Report From the National Cardiovascular Data Registry (NCDR).
J. Am. Coll. Cardiol., June 30, 2009; 54(1): 16 - 24.
[Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
M. Singh, B. J. Gersh, R. J. Lennon, H. H. Ting, D. R. Holmes Jr, B. J. Doyle, and C. S. Rihal
Outcomes of a System-Wide Protocol for Elective and Nonelective Coronary Angioplasty at Sites Without On-site Surgery: The Mayo Clinic Experience
Mayo Clin. Proc., June 1, 2009; 84(6): 501 - 508.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
D. R. Holmes Jr, B. J. Gersh, P. Whitlow, S. B. King III, and J. T. Dove
Percutaneous coronary intervention for chronic stable angina a reassessment.
J. Am. Coll. Cardiol. Intv., February 1, 2008; 1(1): 34 - 43.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Moscucci
Behavioral Factors, Bias, and Practice Guidelines in the Decision to Use Percutaneous Coronary Interventions for Stable Coronary Artery Disease
Arch Intern Med, August 13, 2007; 167(15): 1573 - 1575.
[Full Text] [PDF]


Home page
CirculationHome page
M. Singh, C. S. Rihal, B. J. Gersh, R. J. Lennon, A. Prasad, P. Sorajja, R. E. Gullerud, and D. R. Holmes Jr
Twenty-Five-Year Trends in In-Hospital and Long-Term Outcome After Percutaneous Coronary Intervention: A Single-Institution Experience
Circulation, June 5, 2007; 115(22): 2835 - 2841.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y. Inoue, T. Ueda, S. Taguchi, I. Kashima, K. Koizumi, and S. Noma
Teflon Felt Wrapping Repair for Coronary Perforation After Failed Angioplasty
Ann. Thorac. Surg., December 1, 2006; 82(6): 2312 - 2314.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. H. Ting, G. Raveendran, R. J. Lennon, K. H. Long, M. Singh, D. L. Wood, B. J. Gersh, C. S. Rihal, and D. R. Holmes Jr
A Total of 1,007 Percutaneous Coronary Interventions Without Onsite Cardiac Surgery: Acute and Long-Term Outcomes
J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1713 - 1721.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. A. Bittl
Reducing the Risk of Emergency Bypass Surgery for Failed Percutaneous Coronary Interventions
J. Am. Coll. Cardiol., December 6, 2005; 46(11): 2010 - 2012.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. H. Yang, R. J. Gumina, R. J. Lennon, D. R. Holmes Jr, C. S. Rihal, and M. Singh
Emergency Coronary Artery Bypass Surgery for Percutaneous Coronary Interventions: Changes in the Incidence, Clinical Characteristics, and Indications From 1979 to 2003
J. Am. Coll. Cardiol., December 6, 2005; 46(11): 2004 - 2009.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. P. Wharton Jr, E. C. Keeley, C. L. Grines, T. P. Wharton Jr, E. C. Keeley, and C. L. Grines
The Case for Community Hospital Angioplasty
Circulation, November 29, 2005; 112(22): 3509 - 3534.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. Shanmugam
Tirofiban and emergency coronary surgery
Eur. J. Cardiothorac. Surg., October 1, 2005; 28(4): 546 - 550.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. E. Cutlip and R. E. Kuntz
Cardiac Enzyme Elevation After Successful Percutaneous Coronary Intervention Is Not an Independent Predictor of Adverse Outcomes
Circulation, August 9, 2005; 112(6): 916 - 923.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Bonacchi, E. Prifti, M. Maiani, G. Giunti, and M. Leacche
Skeletonized bilateral internal mammary arteries for non-elective surgical revascularization in unstable angina
Eur. J. Cardiothorac. Surg., July 1, 2005; 28(1): 120 - 126.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. Kerendi, J. D. Puskas, J. M. Craver, W. A. Cooper, E. L. Jones, O. M. Lattouf, J. D. Vega, and R. A. Guyton
Emergency Coronary Artery Bypass Grafting Can Be Performed Safely Without Cardiopulmonary Bypass in Selected Patients
Ann. Thorac. Surg., March 1, 2005; 79(3): 801 - 806.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Karthik, P. Silverton, J. A. Blaxill, and D. J. O'Regan
Successful Outcome of Emergency Coronary Artery Bypass Grafting and Retrieval of Entrapped Stent, Angioplasty Balloon, and Guidewire
Ann. Thorac. Surg., March 1, 2005; 79(3): 1032 - 1034.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. L. Connolly, G. Y.H. Lip, and T. S.N. Lo
Pushing the envelope too far?
J. Am. Coll. Cardiol., November 16, 2004; 44(10): 2094 - 2095.
[Full Text] [PDF]


Home page
JAMAHome page
D. E. Wennberg, F. L. Lucas, A. E. Siewers, M. A. Kellett, and D. J. Malenka
Outcomes of Percutaneous Coronary Interventions Performed at Centers Without and With Onsite Coronary Artery Bypass Graft Surgery
JAMA, October 27, 2004; 292(16): 1961 - 1968.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
W. D. Weaver
Is Onsite Surgery Backup Necessary for Percutaneous Coronary Interventions?
JAMA, October 27, 2004; 292(16): 2014 - 2016.
[Full Text] [PDF]


Home page
CirculationHome page
D. E. Cutlip, A. G. Chhabra, D. S. Baim, M. S. Chauhan, S. Marulkar, J. Massaro, A. Bakhai, D. J. Cohen, R. E. Kuntz, and K. K.L. Ho
Beyond Restenosis: Five-Year Clinical Outcomes From Second-Generation Coronary Stent Trials
Circulation, September 7, 2004; 110(10): 1226 - 1230.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Singh, C. S. Rihal, R. J. Lennon, K. N. Garratt, and D. R. Holmes Jr
Comparison of Mayo Clinic risk score and American College of Cardiology/American Heart Association lesion classification in the prediction of adverse cardiovascular outcome following percutaneous coronary interventions
J. Am. Coll. Cardiol., July 21, 2004; 44(2): 357 - 361.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. R. Holmes Jr, B. G. Firth, and D. L. Wood
Paradigm shifts in cardiovascular medicine
J. Am. Coll. Cardiol., February 18, 2004; 43(4): 507 - 512.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Lotfi, K. Mackie, V. Dzavik, and P. H. Seidelin
Impact of delays to cardiac surgery after failed angioplasty and stenting
J. Am. Coll. Cardiol., February 4, 2004; 43(3): 337 - 342.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. J. Dehmer and D. S. Gantt
Coronary intervention at hospitals without on-site cardiac surgery: are we pushing the envelope too far?
J. Am. Coll. Cardiol., February 4, 2004; 43(3): 343 - 345.
[Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
D. R. Holmes Jr
Risk Stratification and Interventional Cardiology: Robert L. Frye Lecture
Mayo Clin. Proc., December 1, 2003; 78(12): 1507 - 1518.
[Abstract] [PDF]


Home page
Journal Watch CardiologyHome page
Declining Need for Emergency CABG After PCI
Journal Watch Cardiology, December 6, 2002; 2002(1206): 4 - 4.
[Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
106/18/2346    most recent
01.CIR.0000036595.92742.69v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seshadri, N.
Right arrow Articles by Ellis, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seshadri, N.
Right arrow Articles by Ellis, S. G.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Angioplasty
*Coronary Artery Bypass Surgery
Related Collections
Right arrow CV surgery: coronary artery disease